11|2026

Robert J. Johnson, SAP, MAC, LAC
When the Pills Stop Promising
Week one: hope. Week four: a flicker of something, maybe. Week eight: the same heavy fog, now with a
dry mouth and restless nights.
If that sequence sounds familiar, you are far from alone. Antidepressants help millions of people, and for
many they work well. But a substantial share of patients try one medication, then another, and still find
themselves waiting for a lift that never quite arrives. It is discouraging. It can even feel like a personal
failure.
It isn’t.
An incomplete response to medication is a recognized clinical pattern, not a character flaw. And it does
not mean you have run out of options. This article explains what clinicians mean when they say
medication “hasn’t worked,” why no two treatment plans look alike, and when transcranial magnetic
stimulation (TMS) may be worth raising with a qualified provider.
What Clinicians Mean by an “Inadequate Response”
“It didn’t work” can mean very different things. To a clinician, the phrase needs unpacking before any
decision gets made.
Three questions usually come first. Was the dose high enough? Was it taken long enough, typically
several weeks at a therapeutic level? And was it taken consistently? A medication stopped after ten days
because of nausea is not the same as one taken faithfully for two months with little change. Both
matter, but they point toward different next steps.
From there, providers distinguish between a few outcomes:
- Non-response: symptoms barely budge.
- Partial response: things improve somewhat, yet significant symptoms remain.
- Response without remission: you feel noticeably better, but not well. Even this middle ground
carries a higher risk of relapse and ongoing impairment, so it often prompts a change in plan.
Defining treatment-resistant depression
There is no single, universally agreed definition of treatment-resistant depression (TRD). The most
widely used one describes major depression that does not remit after two antidepressant trials of
adequate dose and duration.
Why two? Much of the reasoning traces back to STAR*D, the largest real-world study of sequential
depression treatment. In that trial, roughly half of patients responded to their first SSRI, but only about a
third reached remission. With each additional step, the odds of remission fell. Researchers analyzing the
data identified two failed adequate trials as the point where resistance rose sharply. Later reanalysis have debated the exact percentages, but the overall pattern has held: each new medication tends to
help fewer people than the last.
Why No Two Treatment Plans Look Alike
Two people can share the same diagnosis and need entirely different care. Depression is a label for a
cluster of symptoms, and the biology, history, and circumstances underneath that label vary
enormously.
Several factors shape what a provider recommends next:
- Diagnostic clarity. Before labeling depression “resistant,” a careful clinician revisits the diagnosis
itself. Bipolar disorder, thyroid problems, sleep disorders, and certain medications can all mimic
or worsen depression. - Co-occurring conditions. Anxiety is extremely common alongside depression. In STAR*D, more
than half of participants met criteria for anxious depression, and those patients had notably
lower remission rates. Substance use, chronic pain, and trauma also complicate the picture. - Side-effect tolerance. Some people simply cannot live with the weight gain, emotional blunting,
or sexual side effects certain medications cause, even when the drug is helping. - Health history and life stage. Pregnancy, older age, heart conditions, and other prescriptions
narrow the list of safe options. - Personal priorities. Time, cost, insurance coverage, and comfort with a given approach all count.
Good care is collaborative, not prescriptive.
The takeaway? A medication failing for you says nothing about your willpower. It says something about
fit, and fit can be improved.
Depression Treatment After Antidepressants: Where TMS Fits
When the first or second medication falls short, providers typically consider a few paths. They might
switch to a different drug class, add an augmenting medication, intensify psychotherapy, or combine
approaches. For persistent depression, they may also turn to neuromodulation, which means treating
the brain’s circuits directly rather than through the bloodstream.
TMS for depression belongs in that last category. A coil delivers focused magnetic pulses, similar in
strength to those used in MRI, to brain regions involved in mood regulation. BrainsWay Deep TMS uses
an H-coil inside a padded helmet to reach broader and deeper areas than older figure-8 coils, targeting
the dorsolateral prefrontal cortex.
Crucially, its FDA indication is written for exactly this situation: adults with major depressive disorder
who did not improve satisfactorily on antidepressant medication during their current episode.
When Is TMS Worth Discussing With a Provider?
There is no need to wait until you have exhausted every pill on the shelf. TMS may be worth raising if
any of these sound familiar:
- You have tried at least one antidepressant at an adequate dose and duration, and your
depression has not lifted. - You improved somewhat but never felt truly well.
- Side effects forced you to stop medications that might otherwise have helped.
- You want an evidence-based, non-drug option alongside therapy.
- Your depression comes with significant anxiety, which Deep TMS is also cleared to help reduce
in adults with depression.
Some situations call for extra caution. Non-removable metal in or near the head, such as aneurysm clips
or cochlear implants, generally rules TMS out. A seizure history or certain medications require careful
review.
Bring a few things to that conversation: a list of every antidepressant you have taken, the doses, how
long you stayed on each, and why you stopped. This history helps your provider judge whether TMS is
appropriate, and it often supports insurance approval.
One more option helps you prepare. Colorado TMS Services offers a free online depression self-
assessment that takes only a few minutes and can help you describe your symptoms clearly.
Your Next Step
Treatment-resistant depression is real. So is the progress people make once they find the right
approach.
If antidepressants have left you stuck, talk with the team at Colorado TMS Services in Centennial about
whether BrainsWay Deep TMS is right for you. Call 720-671-0533 or schedule a complimentary
consultation.
If you are in crisis or thinking about suicide, call or text 988 to reach the Suicide & Crisis Lifeline.